Kubaczkova V, Vrabel D, Sedlarikova L, Besse L, Sevcikova S. Cell-free DNA - minimally invasive marker of hematological malignancies. Eur J Haematol. 2017;99(4):291–9.

Article  CAS  PubMed  Google Scholar 

Heitzer E, Haque IS, Roberts CES, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20(2):71–88.

Article  CAS  PubMed  Google Scholar 

Giudice V, Banaszak LG, Gutierrez-Rodrigues F, Kajigaya S, Panjwani R, Ibanez MDPF, Rios O, Bleck CK, Stempinski ES, Raffo DQ, Townsley DM, Young NS. Circulating exosomal microRNAs in acquired aplastic anemia and myelodysplastic syndromes. Haematologica. 2018;103(7):1150–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Talotta D, Almasri M, Cosentino C, Gaidano G, Moia R. Liquid biopsy in hematological malignancies: current and future applications. Front Oncol. 2023;20(13):1164517.

Article  Google Scholar 

Colmenares R, Álvarez N, Barrio S, Martínez-López J, Ayala R. The minimal residual disease using liquid biopsies in hematological malignancies. Cancers (Basel). 2022;14(5):1310.

Article  CAS  PubMed  Google Scholar 

Diaz LA Jr, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol. 2014;32(6):579–86.

Article  PubMed  PubMed Central  Google Scholar 

Oki Y, Neelapu SS, Fanale M, Kwak LW, Fayad L, Rodriguez MA, Wallace M, Klinger M, Carlton V, Kong K, Faham M, Younes A. Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach. Br J Haematol. 2015;169(5):689–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rossi D, Diop F, Spaccarotella E, Monti S, Zanni M, Rasi S, Deambrogi C, Spina V, Bruscaggin A, Favini C, Serra R, Ramponi A, Boldorini R, Foà R, Gaidano G. Diffuse large B-cell lymphoma genotyping on the liquid biopsy. Blood. 2017;129(14):1947–57.

Article  CAS  PubMed  Google Scholar 

Giudice V, Serio B, Errichiello S, Ferrara I, Galdiero A, Bertolini A, Visconti R, De Novellis D, Guariglia R, Luponio S, Morini D, Della Corte AM, Sessa AM, Verdesca F, Langella M, Izzo B, Selleri C. Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition. Eur J Haematol. 2023;111(5):729–41.

Article  CAS  PubMed  Google Scholar 

Groarke EM, Young NS. Aging and Hematopoiesis. Clin Geriatr Med. 2019;35(3):285–93.

Article  PubMed  PubMed Central  Google Scholar 

Heidrich I, Ačkar L, Mossahebi Mohammadi P, Pantel K. Liquid biopsies: potential and challenges. Int J Cancer. 2021;148(3):528–45.

Article  CAS  PubMed  Google Scholar 

Nikanjam M, Kato S, Kurzrock R. Liquid biopsy: current technology and clinical applications. J Hematol Oncol. 2022;15(1):131.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jahangiri L, Hurst T. Assessing the concordance of genomic alterations between circulating-free DNA and tumour tissue in cancer patients. Cancers (Basel). 2019;11(12):1938.

Article  CAS  PubMed  Google Scholar 

Gutierrez-Rodrigues F, Beerman I, Groarke EM, Patel BA, Spitofsky N, Dillon LW, Raffo DQ, Hourigan CS, Kajigaya S, Ferrucci L, Young NS. Utility of plasma cell-free DNA for de novo detection and quantification of clonal hematopoiesis. Haematologica. 2022;107(8):1815–26.

Article  CAS  PubMed  Google Scholar 

Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485–7.

Article  CAS  PubMed  Google Scholar 

Bianchi DW, Chudova D, Sehnert AJ, Bhatt S, Murray K, Prosen TL, Garber JE, Wilkins-Haug L, Vora NL, Warsof S, Goldberg J, Ziainia T, Halks-Miller M. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA. 2015;314(2):162–9.

Article  CAS  PubMed  Google Scholar 

Curnow KJ, Sanderson RK, Beruti S. Noninvasive detection of fetal aneuploidy using next generation sequencing. Methods Mol Biol. 2019;1885:325–45.

Article  CAS  PubMed  Google Scholar 

Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng WJ, Choi JK, Chuang SS, Coupland SE, Czader M, Dave SS, de Jong D, Du MQ, Elenitoba-Johnson KS, Ferry J, Geyer J, Gratzinger D, Guitart J, Gujral S, Harris M, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury J, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi S, Leoncini L, Leung N, Leventaki V, Li XQ, Lim MS, Liu WP, Louissaint A Jr, Marcogliese A, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes-Moreno S, Morice W, Nardi V, Naresh KN, Natkunam Y, Ng SB, Oschlies I, Ott G, Parrens M, Pulitzer M, Rajkumar SV, Rawstron AC, Rech K, Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell W, Siebert R, Sohani AR, Tooze R, Traverse-Glehen A, Vega F, Vergier B, Wechalekar AD, Wood B, Xerri L, Xiao W. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022;36(7):1720–48.

Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97(8):1086–107.

Article  CAS  PubMed  PubMed Central  Google Scholar 

PDQ Adult Treatment Editorial Board. B-Cell Non-Hodgkin Lymphoma Treatment (PDQ®): Health Professional Version. 2024 Feb 2. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 37437080.

Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, Munshi N, Lonial S, Bladé J, Mateos MV, Dimopoulos M, Kastritis E, Boccadoro M, Orlowski R, Goldschmidt H, Spencer A, Hou J, Chng WJ, Usmani SZ, Zamagni E, Shimizu K, Jagannath S, Johnsen HE, Terpos E, Reiman A, Kyle RA, Sonneveld P, Richardson PG, McCarthy P, Ludwig H, Chen W, Cavo M, Harousseau JL, Lentzsch S, Hillengass J, Palumbo A, Orfao A, Rajkumar SV, Miguel JS, Avet-Loiseau H. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17(8):e328–46.

Article  PubMed  Google Scholar 

Younes A, Hilden P, Coiffier B, Hagenbeek A, Salles G, Wilson W, Seymour JF, Kelly K, Gribben J, Pfreunschuh M, Morschhauser F, Schoder H, Zelenetz AD, Rademaker J, Advani R, Valente N, Fortpied C, Witzig TE, Sehn LH, Engert A, Fisher RI, Zinzani PL, Federico M, Hutchings M, Bollard C, Trneny M, Elsayed YA, Tobinai K, Abramson JS, Fowler N, Goy A, Smith M, Ansell S, Kuruvilla J, Dreyling M, Thieblemont C, Little RF, Aurer I, Van Oers MHJ, Takeshita K, Gopal A, Rule S, de Vos S, Kloos I, Kaminski MS, Meignan M, Schwartz LH, Leonard JP, Schuster SJ, Seshan VE. International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017). Ann Oncol. 2017;28(7):1436–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ottaiano A, Ianniello M, Petrillo N, Santorsola M, De Falco L, Castaldi SG, Castaldi MA, Giudice V, Selleri C, Savarese G. Non-invasive prenatal testing can detect silent cancers in expecting mothers. Genes Dis. 2023;11(2):585–8.

Article  PubMed  PubMed Central  Google Scholar 

De Falco L, Savarese G, Savarese P, Petrillo N, Ianniello M, Ruggiero R, Suero T, Barbato C, Mori A, Ramiro C, Della Corte L, Saccone G, Di Spiezio SA, Fico A. Clinical experience with genome-wide noninvasive prenatal screening in a large cohort of twin pregnancies. Genes (Basel). 2023;14(5):982.

Article  PubMed  Google Scholar 

La Verde M, De Falco L, Torella A, Savarese G, Savarese P, Ruggiero R, Conte A, Fico V, Torella M, Fico A. Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies. BMC Med Genom. 2021;14(1):93.

Article  Google Scholar 

Atrash S, Flahavan EM, Xu T, Ma E, Karve S, Hong WJ, Jirau-Lucca G, Nixon M, Ailawadhi S. Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysis. Blood Cancer J. 2022;12(3):46.

Article  PubMed  PubMed Central  Google Scholar 

Shago M. Recurrent cytogenetic abnormalities in acute lymphoblastic leukemia. Methods Mol Biol. 2017;1541:257–78.

Article  CAS  PubMed  Google Scholar 

Prakash G, Kaur A, Malhotra P, Khadwal A, Sharma P, Suri V, Varma N, Varma S. Current role of genetics in hematologic malignancies. Indian J Hematol Blood Transfus. 2016;32(1):18–31.

Article  PubMed  Google Scholar 

Latham S, Hughes E, Budgen B, Ross D, Greenwood M, Bradstock K, Dalla-Pozza L, Huang L, Law T, Doculara L, Venn N, Ullah S, Sutton R, Morley AA. Sensitive measurement of minimal residual disease in blood by HAT-PCR. J Mol Diagn. 2022;24(6):632–41.

Article  CAS  PubMed  Google Scholar 

Short NJ, Kantarjian H, Ravandi F, Konopleva M, Jain N, Kanagal-Shamanna R, Patel KP, Macaron W, Kadia TM, Wang S, Jorgensen JL, Khoury JD, Yilmaz M, Kebriaei P, Takahashi K, Garcia-Manero G, Daver N, Post SM, Huang X, Kornblau SM, Pelletier S, Flores W, Matthews J, Garris R, Jabbour E. High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse. Blood Adv. 2022;6(13):4006–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bronkhorst AJ, Ungerer V, Holdenrieder S. The emerging role of cell-free DNA as a molecular marker for cancer management. Biomol Detect Quantif. 2019;18(17): 100087.

Article  Google Scholar 

Grabuschnig S, Bronkhorst AJ, Holdenrieder S, Rosales Rodriguez I, Schliep KP, Schwendenwein D, Ungerer V, Sensen CW. Putative origins of cell-free DNA in humans: a review of active and passive nucleic acid release mechanisms. Int J Mol Sci. 2020;21(21):8062.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reece M, Saluja H, Hollington P, Karapetis CS, Vatandoust S, Young GP, Symonds EL. The use of circulating tumor DNA to monitor and predict response to treatment in colorectal cancer. Front Genet. 2019;21(10):1118.

Article  Google Scholar 

Li H, Jing C, Wu J, Ni J, Sha H, Xu X, Du Y, Lou R, Dong S, Feng J. Circulating tumor DNA detection: a potential tool for colorectal cancer management. Oncol Lett. 2019;17(2):1409–16.

CAS  PubMed  Google Scholar 

Zhang BO, Xu CW, Shao Y, Wang HT, Wu YF, Song YY, Li XB, Zhang Z, Wang WJ, Li LQ, Cai CL. Comparison of droplet digital PCR and conventional quantitative PCR for measuring EGFR gene mutation. Exp Ther Med. 2015;9(4):1383–8.

Article